Bristol Myers Squibb Co. (BMY)
66.58
-0.37
(-0.55%)
USD |
NYSE |
Aug 28, 16:00
66.57
-0.01
(-0.02%)
After-Hours: 20:00
Bristol Myers Squibb Cash and Short Term Investments (Quarterly) : 11.07B for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 11.07B |
| March 31, 2026 | 10.49B |
| December 31, 2025 | 10.67B |
| September 30, 2025 | 16.50B |
| June 30, 2025 | 13.62B |
| March 31, 2025 | 11.78B |
| December 31, 2024 | 10.86B |
| September 30, 2024 | 8.096B |
| June 30, 2024 | 6.655B |
| March 31, 2024 | 9.672B |
| December 31, 2023 | 12.34B |
| September 30, 2023 | 7.739B |
| June 30, 2023 | 8.783B |
| March 31, 2023 | 9.322B |
| December 31, 2022 | 9.401B |
| September 30, 2022 | 9.191B |
| June 30, 2022 | 13.42B |
| March 31, 2022 | 15.35B |
| December 31, 2021 | 17.36B |
| September 30, 2021 | 15.96B |
| June 30, 2021 | 14.19B |
| March 31, 2021 | 13.28B |
| December 31, 2020 | 16.54B |
| September 30, 2020 | 21.36B |
| June 30, 2020 | 21.88B |
| Date | Value |
|---|---|
| March 31, 2020 | 18.32B |
| December 31, 2019 | 15.39B |
| September 30, 2019 | 32.54B |
| June 30, 2019 | 29.36B |
| March 31, 2019 | 8.764B |
| December 31, 2018 | 8.884B |
| September 30, 2018 | 6.83B |
| June 30, 2018 | 6.075B |
| March 31, 2018 | 6.77B |
| December 31, 2017 | 6.812B |
| September 30, 2017 | 7.122B |
| June 30, 2017 | 6.505B |
| March 31, 2017 | 6.109B |
| December 31, 2016 | 6.35B |
| September 30, 2016 | 5.56B |
| June 30, 2016 | 4.651B |
| March 31, 2016 | 4.307B |
| December 31, 2015 | 4.27B |
| September 30, 2015 | 5.413B |
| June 30, 2015 | 5.476B |
| March 31, 2015 | 7.607B |
| December 31, 2014 | 7.435B |
| September 30, 2014 | 7.221B |
| June 30, 2014 | 7.175B |
| March 31, 2014 | 7.059B |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Johnson & Johnson | 20.76B |
| Eli Lilly & Co. | 8.95B |
| Merck & Co., Inc. | 7.182B |
| Pfizer Inc. | 11.70B |
| AstraZeneca PLC | 7.675B |